View abstract

Cet abstract a été assigné à sessions
TitreFAST® questionnaire: a short and effective tool to assess OSD in glaucoma patients
ButOcular Surface Disease (OSD) remains an underrecognized condition in glaucoma patients. It is well known that OSD may compromise the tolerability for and compliance with topical therapy. Therefore, identification of OSD is important. The FAST (Fast Assessment of ocular Surface Trouble) questionnaire has been developed to facilitate OSD diagnosis.
MéthodesA survey in 6 European countries (BE, FR, IT, PL, SP, UK) has been implemented to evaluate the FAST questionnaire. It includes 14 short questions to collect risk factors, symptoms and ocular signs of OSD. Both data from the patient interview and from the clinical examination are collected.
Résultats1278 patients were recruited, of which 185 Belgian patients. The Belgian results are presented for the first time. 60.5% were using at least one preserved glaucoma treatment. At least one risk factor for OSD was observed in 57.3% of patients. 54.5% of patients were taking two or more preserved glaucoma drops per day. 99.5% reported ocular symptoms, including dry eye, itching/irritation and burning sensation, in 42.4%, 37.5% and 35.9% of patients, respectively. In 99.5% at least one ocular sign was reported: 56.5% of patients had conjunctival hyperemia; 29.4% and 21.2% presented with corneal and conjunctival fluorescein staining, respectively. Only 31.7% of patients had a tBUT superior to 10 seconds.
ConclusionThese results offer interesting insight into the prevalence of OSD in Belgium and also highlight the simplicity of this tool to report symptoms and clinical signs of OSD, rendering the FAST questionnaire a useful aid for ophthalmologists in daily practice.
Conflit d'intérêtOui
Détails conflits d'intérêtconsultant voor Théa Pharma
Auteur 1
NomSTALMANS
InitialesI
InstitutUZ Leuven
VilleLeuven
Auteur 2
Nomthe Belgian FAST Study group
Auteur 3
NomBaudouin
InitialesC
InstitutInstitut Quinze-Vingts
VilleParijs
top ^